|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-12-22
|
|
pubmed:abstractText |
Cardiac surgical patients are at an approximate 1% to 2% risk of experiencing heparin-induced thrombocytopenia (HIT), a severe immune-mediated disease that is associated with thromboembolic events. We assessed the occurrence of this disease and its influence on clinical outcome in patients after implantation of a ventricular assist device (VAD).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1552-6259
|
|
pubmed:author |
pubmed-author:DrewsThorstenT,
pubmed-author:HetzerRolandR,
pubmed-author:HueblerSabineS,
pubmed-author:JurmannMichaelM,
pubmed-author:KosterAndreasA,
pubmed-author:KuppeHermannH,
pubmed-author:LoebeMatthiasM,
pubmed-author:MeyerOliverO,
pubmed-author:PasicMiralemM,
pubmed-author:PotapovEvgenijE,
pubmed-author:WengYuguoY
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
83
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
72-6
|
|
pubmed:dateRevised |
2008-1-25
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Impact of heparin-induced thrombocytopenia on outcome in patients with ventricular assist device support: single-institution experience in 358 consecutive patients.
|
|
pubmed:affiliation |
Department of Anesthesia, Deutsches Herzzentrum Berlin, Germany. koster@dhzb.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
